91797-61-4

Upstream product

• 52789-19-2 1-Methylimino-4-phenyl-1,2,3,4-tetrahydronaphthalin 
• 52758-03-9 (+/-)-cis-1-Methylamino-4-phenyltetralin 
• 14578-68-8 4-phenyl-3,4-dihydronaphthalen-1(2H)-one 

Downstream Products

• 14578-68-8 4-phenyl-3,4-dihydronaphthalen-1(2H)-one 
• 52789-19-2 1-Methylimino-4-phenyl-1,2,3,4-tetrahydronaphthalin 
• 339560-30-4 Ethyl-[4-phenyl-3,4-dihydro-2H-naphthalen-(1E)-ylidene]-amine 
• 54308-60-0 Isopropyl-[4-phenyl-3,4-dihydro-2H-naphthalen-(1E)-ylidene]-amine 
• 52795-04-7 trans-dl-N-methyl-4-phenyl-1,2,3,4-tetrahydro-1-naphthylamine 
• 52758-03-9 (+/-)-trans-1-Methylamino-4-phenyltetralin 
• 52371-40-1 (+/-)-trans-1-Dimethylamino-4-phenyltetralin 
• 52795-02-5 CP 24441 
• 52371-40-1 (+/-)-cis-1-Dimethylamino-4-phenyltetralin 

Relevant academic research and scientific papers

Aminophenyltetralin compounds

A series of novel 4-phenyl-1,2,3,4-tetrahydro-1-naphthylamines, including their pharmaceutically acceptable acid addition salts and their cis- and trans-isomers, have been prepared. The trans-isomers are useful in the field of mental health as antidepressant agents and/or as psychomotor stimulants. The trans-isomer of N-methyl-4-phenyl-1,2,3,4-tetrahydro-1-naphthylamine represents a preferred embodiment.